Biotech Knockoffs Lure Novartis

Biotech Knockoffs Lure Novartis
“A big pharma player is expanding its generics business. Expect others to follow
The divide between those making brand-name drugs and those producing generics is about to become a bit less clear. “


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: